نتایج جستجو برای: efavirenz

تعداد نتایج: 2276  

2011
N. APPALA RAJU

A simple, precise, rapid and accurate reverse phase HPLC method in isocratic mode has been developed for the estimation of Tenofovir disoproxil, Emtricitabine and Efavirenz in tablet dosage form. A Hypersil BDS C18, 250x4.6 mm, 5 μm partical size, with mobile phase consisting of acetonitrile and 0.03 M KH2PO4 water (pH adjusted to 3.2 with orthophosphoric acid) in the ratio of 60:40 v/v was use...

2016
Christine Njuguna Annoesjka Swart Marc Blockman Gary Maartens Briony Chisholm Annemie Stewart Anri Uys Karen Cohen

BACKGROUND Gynaecomastia is associated with exposure to antiretroviral therapy (ART), in particular efavirenz. There is limited data on clinical characteristics of patients with ART-associated gynaecomastia in resource-limited settings and little guidance on the optimal management of this adverse drug reaction (ADR). We describe the clinical characteristics, management and outcomes of gynaecoma...

Journal: :The Journal of antimicrobial chemotherapy 2012
Wiete Kromdijk Jan W Mulder Hilde Rosing Patrick M Smit Jos H Beijnen Alwin D R Huitema

OBJECTIVES Plasma concentrations are frequently used for therapeutic drug monitoring of antiretroviral drugs. Dried blood spot sampling offers a patient-friendly and easy alternative to plasma sampling. However, dried blood spot concentrations are not necessarily equal to plasma concentrations and therefore the objective of this work was to establish the relationship between nevirapine and efav...

2015
Nilesh B. Bhatt Elisabeth Baudin Bindiya Meggi Carlota da Silva Aurélie Barrail-Tran Valérie Furlan Beatriz Grinsztejn Maryline Bonnet Anne-Marie Taburet Ilesh V. Jani Nádia Sitoe Adolfo Vubil Maria Nhadzombo Fernando Sitoe Delário Nhumaio Odete Bule Kátia Cossa Rui Bastos Elizabete Nunes Paula Samo Gudo Josué Lima Mie Okamura Laura Ciaffi Agnès Sobry Mariano Lugli Bruno Lab Avertino Barreto Christophe Michon Alexandra Calmy Alpha Diallo Christine Rouzioux

OBJECTIVES We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial. METHODS Participants were randomly selected to receive either nevirapine at 200 mg twice daily (n = 256) or efavirenz at 600 mg daily (n = 270), both combined with two nucleoside analogue...

2013
Princy Kumar Edwin DeJesus Gregory Huhn Louis Sloan Catherine Butkus Small Howard Edelstein Franco Felizarta Ritche Hao Lisa Ross Britt Stancil Keith Pappa Belinda Ha

BACKGROUND Rates of cardiovascular disease are higher among HIV-infected patients as a result of the complex interplay between traditional risk factors, HIV-related inflammatory and immunologic changes, and effects of antiretroviral therapy (ART). This study prospectively evaluated changes in cardiovascular biomarkers in an underrepresented, racially diverse, HIV-1-infected population receiving...

Journal: :Journal of acquired immune deficiency syndromes 2009
Martin Markowitz Bach-Yen Nguyen Eduardo Gotuzzo Fernando Mendo Winai Ratanasuwan Colin Kovacs Guillermo Prada Javier O Morales-Ramirez Clyde S Crumpacker Robin D Isaacs Havilland Campbell Kim M Strohmaier Hong Wan Robert M Danovich Hedy Teppler

OBJECTIVES The purpose of this study was to evaluate the safety and efficacy of raltegravir vs efavirenz-based antiretroviral therapy after 96 weeks in treatment-naive patients with HIV-1 infection. METHODS Multicenter, double-blind, randomized study of raltegravir (100, 200, 400, or 600 mg twice a day) vs efavirenz (600 mg every day), both with tenofovir/lamivudine (TDF/3TC), for 48 weeks, a...

Journal: :Molecular pharmacology 2015
Luc Bertrand Michal Toborek

Increasing evidence demonstrates that the antiretroviral drugs (ARVds) used for human immunodeficiency virus (HIV) treatment have toxic effects that result in various cellular and tissue pathologies; however, their impact on the cells composing the blood-brain barrier is poorly understood. The current study focused on ARVds, used either in combination or alone, on the induction of endoplasmic r...

2015
Richard M Hoglund Pauline Byakika-Kibwika Mohammed Lamorde Concepta Merry Michael Ashton Warunee Hanpithakpong Nicholas P J Day Nicholas J White Angela Äbelö Joel Tarning

AIM Drug-drug interactions between antimalarial and antiretroviral drugs may influence antimalarial treatment outcomes. The aim of this study was to investigate the potential drug-drug interactions between the antimalarial drugs, lumefantrine, artemether and their respective metabolites desbutyl-lumefantrine and dihydroartemisinin, and the HIV drugs efavirenz, nevirapine and lopinavir/ritonavir...

Journal: :Molecular pharmacology 2008
Namandjé N Bumpus Paul F Hollenberg

Human P450 2B6 is a polymorphic enzyme involved in the oxidative metabolism of a number of clinically relevant substrates. The lysine 262-to-arginine mutant of cytochrome P450 2B6 (P450 2B6.4) has been shown to have differential effects on P450 2B6 catalytic activity. We reported previously that the mutant enzyme was unable to metabolize 17-alpha-ethynylestradiol (17EE) or become inactivated by...

Journal: :Annals of internal medicine 2009
Alicia Gutiérrez-Valencia Pompeyo Viciana Rosario Palacios Rosa Ruiz-Valderas Fernando Lozano Alberto Terrón Antonio Rivero Luis F López-Cortés

BACKGROUND More than 50% of patients who start efavirenz treatment develop limiting neuropsychiatric adverse events (NPAEs). OBJECTIVE To assess whether stepwise dosing of efavirenz decreases the incidence and severity of NPAEs while maintaining virologic efficacy. DESIGN Randomized, double-blind, controlled trial. SETTING 7 HIV clinics in Spain. PATIENTS 114 HIV-infected patients eligi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید